Using MSK-Integrated Mutation Profiling of Actionable Cancer Targets (IMPACTTM), a deep-coverage-targeted sequencing analysis of 410 key cancer-associated genes27; we sequenced these tumours and confirmed the presence of common genetic alterations typical of HNSCC, including PIK3CA activating mutations (Supplementary Table 1). This evidence concerns the gene PIK3CA and cancer.